approach to compare different valve implants and could aid future novel valve designs.
Introduction
In high-risk patients with severe aortic stenosis, trans-catheter aortic valve replacement using transcatheter aortic valve implants (TAVI) has evolved into a widely used alternative to surgical aortic valve replacement, especially due to its minimal-invasive character. The treatment decision in favour for TAVI is currently determined by several factors including age and comorbid conditions [1] and the treatment has to date shown good outcomes [2] [3] [4] [5] [6] [7] [8] . While several differing TAVI designs exist, prostheses share the need of an easy delivery, a long-term durability, a strong fixation permitting coronary blood flow and optimal hemodynamic conditions [9] . Nevertheless, hemodynamic changes occurring after TAVI are known to play a crucial role for the outcome and still differ from physiologically optimal conditions [10, 11] .
In blood, the conversion of mechanical energy to heat is an irreversible process, disturbing the energy balance of the heart [12] . At high Reynolds numbers, kinetic energy loss due to turbulence (turbulent kinetic energy: TKE) is known to play a major role for energy dissipation into heat and quantification of these losses is thought to represent a measure of pathophysiological conditions including irreversible pressure loss, increased cardiac afterload and damage to blood constituents and/or to the vessel wall [13] [14] [15] .
Currently, invasive catheter-based pressure recordings represent the gold standard for estimating an irreversible pressure loss. Due to the invasive nature of this approach,
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The purpose of the present work is to demonstrate the use of highly accelerated velocity and TKE mapping to accurately evaluate time-resolved velocity and TKE distributions in various TAVI models in vitro. In combination with an acceleration method termed k-t PCA [24] , five different TAVI models were studied and compared in this in vitro setting.
Materials and methods

Experimental set-up
The setup was designed in order to comply with the recommended settings for inactive surgical implants [25] . A pulsatile flow pump (CardioFlow 5000MR, Shelley Medical Imaging Technologies, Ontario, Canada) was placed outside the MRI suite and connected to a closed circuit. The elastic modulus of the tubing was 3.2 MPa, corresponding to pulse wave velocities (using the Moens-Korteweg relationship) in the order of 14-16 m/s. Previous studies in healthy volunteers and patients with pulse wave velocities reached 11 m/s in elderly healthy and 18 m/s in patients [26, 27] . In order to achieve physiological conditions, the TAVI devices were inserted via valvuloplasty into the 25 mm diameter compliant tube with sufficient (200 mm) inflow and outflow lengths avoiding flow disturbances from upstream angles and pulse reflections from downstream connectors. The pulsatile waveform was adjusted to resemble a healthy physiological flow of the left ventricular outflow tract (ECG cycle length 900 ms, stroke volume 35.8 ± 2.9 ml, peak velocity 1.8 m/s). Retrograde flow was needed in order to assure a correct closure of all valves in early diastole. To add retrograde flow via the pump while avoiding that the compliant tubing collapses following valve closure, the diastolic pressure distal to the valve was increased by additionally including a stenosis at the outflow of the tube (>1.5 m distal to the valves). To simulate blood viscosity, a 40/60% mixture of glycerol/water was used. The five different TAVI models listed in Fig. 1 were analysed. The orifice areas of the valves were determined by insertion of a gauge (Hegar dilator).
Data acquisition and reconstruction
Data were acquired on a clinical 3T Ingenia system (Philips Healthcare, Best, The Netherlands) using a 16-channel anterior coil combined with the 12-channel posterior coil. The trigger signal from the pump was used to synchronise the MRI measurements. Time-resolved multi-point 4D Flow data were acquired with following scan parameters: sagittal volume, field of view 305 × 167 × 40 mm 3 , spatial resolution 2 × 2 × 3 mm 3 , prospective ECG-triggering, temporal resolution 38 ms, flip angle 7°, TR/TE 6.5/3.8 ms, and velocity encoding values (VENC) 30, 50, 80, 110 and 180 cm/s. The largest VENC was chosen in order to avoid aliasing in all valves, the smallest VENC was chosen in order to avoid long echo times. The three intermediate VENCs were chosen arbitrarily [22, 28] . A nominal undersampling factor of 8 in combination with a k-t principal component analysis (k-t PCA) reconstruction was used [24] . Data reconstruction was performed offline using Recon-Frame (Gyrotools, Winterthur, Switzerland), where each velocity encoded image was reconstructed separately and included a correction for concomitant fields and eddy-current induced phase offsets [29, 30] . With the magnitude and velocity information of the images, a Bayesian reconstruction was performed to reconstruct spatial maps of timeresolved velocities and TKE [22] .
Data analysis
Data analysis was performed using GTFlow (Gyrotools, Winterthur, Switzerland) in combination with in-house tools (Matlab, Natick, MA, USA). Three-dimensional visualisations with overlaying velocity and TKE values were generated, followed by a region-of-interest (ROI)-wise analysis at several locations along the tube. ROIs at positions −50, −20, 20, 40, 60, 80, 100 mm relative to the valve position (0 mm) of the TAVI were drawn on slices perpendicular to the tube. The sizes and in-plane positions of the ROIs were adjusted for each cardiac phase. Due to MRI signal dropouts at the location of metal stents around the valves, the closest ROIs were drawn 20 mm distal to the TAVI. Each ROI was quantitatively analysed. In order to depict the temporal evolution of TKE and velocities, the temporal evolution of the mean values averaged over the ROI were plotted. Furthermore, a pixel-wise histogram (pixel-count) was generated for each ROI and every time-point in order to analyse value distributions. The histograms were generated by defining 100 value bins ranging from −0.5 to 2 m/s for the throughplane velocities (v TP ) and from 0 to 500 J/m 3 for the TKE plots. The number of pixels having values falling into each bin were counted, leading to a histogram. These histograms were color-coded on an inverse grayscale map with black corresponding to 15 or more pixels and white corresponding to 0 pixels. Finally, the TKE and v TP integrated over one cardiac cycle and averaged over all ROIs, were plotted.
Results
A scan time of 13 min per TAVI was achieved. All five valves showed good functioning with visually verified full leaflet expansion and without paravalvular leaks. Signal voids were observed in the direct vicinity of each valve, while the greatest artefact load was observed in TAVI 1 due to the large surrounding stent. The ROIs closest to the valves (20 mm), however, were unaffected by the artefacts and could be successfully analysed in all valves.
As compared to mechanical and bileaflet valves, all TAVI valves open in a centric geometry, giving rise to a single, symmetric jet in peak systole reaching up to 1.8 m/s in our setup, depending on the valve. Analysed TKE values were maximal at the ROI levels 20 mm distal to the TAVI (C3). Figure 2 shows a screenshot of overlaid velocity and TKE values in all valves. A video (Vid. 1) showing the time-evolution along the cardiac cycle can be found in the supplementary material. A movie (Vid. 2) showing the velocity pathlines of all five TAVI valves and an image showing a still of this movie (Fig. 1s ) are also included in the supplementary material.
Time-resolved plots of pixel distributions (histograms) along with mean v TP and TKE are shown in Fig. 3 . The solid red line represents the mean through-plane velocity or TKE value within the ROI, whereas the histograms in the background images show the distributions of through-plane velocity or TKE values. For all valves, highest velocities and TKE values were observed in C3 and at peak systole. Different TKE values were observed between models, ranging from peak TKE values of just over 100 J/m 3 (TAVI 1) to values over 500 J/m 3 (TAVI 2). As expected, mean v TP were similar for all valves, while velocity distributions varied, ranging from peak velocities of 1 m/s (TAVI 1) to peak velocities of 1.8 m/s (TAVI 2). As compared to TAVI 1, larger ranges of velocities are found in TAVI 2 and 4 at the level of C3, which indicates multi-directional velocity distributions.
TAVI 1 showed lowest TKE values while demonstrating a noticeable regurgitant flow attributed to a slight valve insufficiency (backward flow through the closed valve), leading to elevated TKE values in early diastole (C2 level in Fig. 3 , arrow). Figure 4 summarises the results, showing integrated v TP and TKE values over one ECG cycle, averaged over all pixels within all ROIs. The reduction of the integrated v TP during valve closure at approximately 0.5 s is mainly attributed to the retrograde flow needed to close the valve. While mean v TP showed a similar pattern for all TAVIs, TKE values differed strongly in amplitude, leading to the cumulative values shown in the table in Fig. 4 . The Pearson's correlation coefficient between orifice area and cumulative TKE values was r = −0.61.
Discussion
The present study proposes a technique to measure timeresolved velocities and TKE in TAVIs in clinically acceptable scan times and demonstrates its use in an in vitro characterization of several TAVIs from different vendors.
To our knowledge, the present study provides the first in vitro comparison of flow and TKE values in different TAVI valves. In order to allow translation into future in vivo studies, a k-t acceleration was used for data acquisition. To allow accurate velocity and TKE measurements, a multi-VENC acquisition in combination with a Bayesian unfolding algorithm was applied. Due to scan time limitations, the choice of five velocity encoding values (30, 50, 80, 110 and 180 cm/s) was only possible in combination with the used data undersampling factor of 8 leading to a scan time of approximately 13 min. For a Bayesian reconstruction (as used in our work), Xing et al. [28] showed that a nonuniform sampling of VENC values leads to smaller fitting errors than a uniformly sampling. As discussed by Binter et al. [22] , the maximum VENC (180 cm/s in our work) should be chosen to avoid velocity aliasing and the lowest VENC (30 cm/s in our work) is limited by longer echo times (potentially leading to longer scan times). Future work has to be done, however, to analyse the effect of the number and the spectrum of velocity encoding values on data accuracy.
Expanding on previous studies, which analysed flow dynamics including TKE in four surgically implantable aortic valves using steady flow and a rigid plexiglas phantom [23] or in one mechanical and one TAVI valve using pulsatile flow and a dedicated flow chamber [22] , we aimed at mimicking physiological flow conditions more closely by using a pulsatile flow waveform in combination with a compliant tubing resembling the aortic stiffness reported for elderly patients [26, 27] . Even though the use of a compliant tubing is an improvement over previous in vitro set-ups, our set-up lacks to simulate the typically anatomy of the ascending aorta and the aortic arch. It is known that the geometry of the ascending aorta affects the eccentricity of flow and therewith the hemodynamics downstream of the valve [31] . Due to the symmetric design of the TAVIs, which is in-line with the symmetry seen in the measured spatial velocity and TKE distributions, the implant orientation, however, might not be as important as for other, non-symmetric, valve designs (such as bi-leaflet valves). Nevertheless, future work will be required to analyse velocity and TKE distributions in anatomically realistic models as well as in vivo.
We detected highest TKE values closest downstream to the implants and at time-points of highest velocities, which is in line with previous findings [23] . A measurement at Across the tested TAVI models we observed large differences in distributions of velocities and TKE values. While all TAVI models were accurately placed and no paravalvular leaks were observed, the lower TKE values observed in TAVI 1 might be attributed to the larger effective valve orifice area. However, the fact that valve orifice area is not the only determinant of TKE is demonstrated by the comparison of TAVI 2 and 3, both values exhibiting the same orifice area but different TKE values.
Although it might seem consequential to correlate the measured velocity with the TKE values, it must remain clear that both parameters are fundamentally different [32] : while velocity corresponds to macroscopic, laminar motion which may or may not be 'ordered' (non-'ordered' flow includes vortices or helices), TKE is a measure of energy dissipated into heat, which cannot be calculated from the 4D Flow velocity field. The complementarity of both parameters can be seen exemplarily in the results of TAVI 3: while peak through-plane velocities were higher at C3 than at C4, TKE values at both ROIs were similar (and even slightly elevated at C4 when compared to C3). The large variance in TKE values across different valves and the limited correlation with other parameters in this study underline its uniqueness and potential as an important measure for valve design optimisation.
The precise clinically significance of increased TKE values still remains to be elucidated. However, it appears well conceivable that increased TKE values and the associated loss of kinetic energy will result in an increased flow resistance, an increased afterload and, as a consequence, in a higher cardiac burden.
Moreover, future studies will have to demonstrate, whether increased TKE values are associated with surrogate markers of blood cell damage and haemolysis.
Limitations of the current study design include the comparatively low stroke volume and peak velocities. The peak velocities in the current setting (180 cm/s) are slightly lower than previously reported velocities in in vivo TAVI patients (2.07 ± 0.34 m/s in [11] and 2.3 ± 0.41 m/s in [33] ). As TKE can be assumed to scale with velocity squared, measured in vivo TKE values are expected to be scaled higher than reported here.
Another limitation is to be attributed to the rapid technical development of valve designs which results in three of the currently investigated TAVI models no longer being in clinical use in Europe.
A limitation in the analysis method is related to the fact that data analysis and presentation were mainly performed on 2D ROIs and not 3D volumes. This is primarily due to the ease of data handling, presentation and available postprocessing tools.
Finally, physiological significance of elevated TKE values remains to be determined and its correlations with MRI-derived parameters such as myocardial strain, cardiac remodelling, myocardial fibrosis or thrombus formation is warranted in future in vivo studies. 
Conclusion
In conclusion, the current study proposes an in vitro setting that is readily usable for newly developed valve designs, not necessarily limited to TAVI models. In the studied TAVI models, strong variations of velocity and TKE distributions and maximum values were measured using highly accelerated multi-point 4D Flow MRI under controlled in vitro conditions. The standardised setup and measurement protocol allows a comparison of implants and could aid technical development of TAVI models. The acquisition and reconstruction protocol as well as the suggested quantitative analysis will allow an easy transfer to further in vivo studies. Future studies are needed to elucidate the physiological role of increased TKE values and its determining factors. These future studies will help to promote a better understanding of the impact of implant design on patient outcome after TAVI procedure.
